Drug-induced liver injury associated with antinuclear antibodies.
Ohmoto
K
K
Yamamoto
S
S
D000328:Adult; D000368:Aged; D000700:Analgesics / Q000009:adverse effects; D018712:Analgesics, Non-Narcotic / Q000009:adverse effects; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000974:Antibodies, Antinuclear / Q000276:immunology*; D000925:Anticoagulants / Q000009:adverse effects; D001327:Autoimmune Diseases / Q000150:complications / Q000276:immunology*; D002317:Cardiovascular Agents / Q000009:adverse effects; D056486:Chemical and Drug Induced Liver Injury / Q000150:complications / Q000209:etiology* / Q000276:immunology*; D018492:Dopamine Antagonists / Q000009:adverse effects; D005260:Female; D005765:Gastrointestinal Agents / Q000009:adverse effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D013997:Time Factors
D000700:Analgesics; D018712:Analgesics, Non-Narcotic; D000900:Anti-Bacterial Agents; D000974:Antibodies, Antinuclear; D000925:Anticoagulants; D002317:Cardiovascular Agents; D018492:Dopamine Antagonists; D005765:Gastrointestinal Agents